Elaine M. Hylek MD

Professor, General Internal Medicine

801 Massachusetts Ave | (617) 414-3743
Elaine Hylek
Sections

General Internal Medicine

Centers

Evans Center for Interdisciplinary Biomedical Research

Biography

Expertise includes: Arterial Thrombosis; Venous Thrombosis; Atrial Fibrillation; Safety and Effectiveness of Antithrombotic Therapy.

Education

MD, University of Pittsburgh School of Medicine, 1988

MPH, Harvard School of Public Health, 1993

Health Administration/Education, MS, University of Pittsburgh, 1984

Medical Technologist, BS, Pennsylvania State University, 1978

Publications

Published on 8/4/2021

Rasmussen PV, Hylek E. Persistence with treatment in atrial fibrillation: still a pressing issue in the era of direct oral anticoagulants. Eur Heart J. 2021 Aug 04. PMID: 34347053.

Published on 7/1/2021

Albers GW, Bernstein R, Brachmann J, Camm AJ, Fromm P, Goto S, Granger CB, Hohnloser SH, Hylek E, Krieger D, Passman R, Pines JM, Kowey P. Reexamination of the Embolic Stroke of Undetermined Source Concept. Stroke. 2021 Aug; 52(8):2715-2722. PMID: 34192898.

Published on 3/1/2021

Pol T, Hijazi Z, Lindb├Ąck J, Alexander JH, Bahit MC, De Caterina R, Eikelboom JW, Ezekowitz MD, Gersh BJ, Granger CB, Hylek EM, Lopes R, Siegbahn A, Wallentin L. Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas. Open Heart. 2021 03; 8(1). PMID: 33741689.

Published on 9/15/2020

Hylek EM. The importance of adherence and persistence in the elderly atrial fibrillation patient. Eur Heart J Suppl. 2020 Sep; 22(Suppl I):I38-I42. PMID: 33088233.

Published on 9/1/2020

Hijazi Z, Oldgren J, Lindb├Ąck J, Alexander JH, Alings M, De Caterina R, Eikelboom JW, Ezekowitz MD, Held C, Huber K, Hylek EM, Granger CB, Lopes RD, Vinereanu D, Siegbahn A, Wallentin L. Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials. JAMA Netw Open. 2020 09 01; 3(9):e2015943. PMID: 32936298.

Published on 8/3/2020

Williams BA, Chamberlain AM, Blankenship JC, Hylek EM, Voyce S. Trends in Atrial Fibrillation Incidence Rates Within an Integrated Health Care Delivery System, 2006 to 2018. JAMA Netw Open. 2020 08 03; 3(8):e2014874. PMID: 32857147.

Published on 8/1/2020

Aulin J, Hijazi Z, Siegbahn A, Andersson U, Alexander JH, Connolly SJ, Ezekowitz MD, Gersh BJ, Granger CB, Horowitz J, Hylek EM, Lopes RD, Yusuf S, Wallentin L, Oldgren J. Serial measurement of interleukin-6 and risk of mortality in anticoagulated patients with atrial fibrillation: Insights from ARISTOTLE and RE-LY trials. J Thromb Haemost. 2020 09; 18(9):2287-2295. PMID: 32510737.

Published on 7/12/2020

Madhavan M, Holmes DN, Piccini JP, Freeman JV, Fonarow GC, Hylek EM, Kowey PR, Mahaffey KW, Pieper K, Peterson ED, Chan PS, Allen LA, Singer DE, Naccarelli GV, Reiffel JA, Steinberg BA, Gersh BJ. Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF). Am J Cardiol. 2020 10 01; 132:66-71. PMID: 32826041.

Published on 6/26/2020

Geurink K, Holmes D, Ezekowitz MD, Pieper K, Fonarow G, Kowey PR, Reiffel JA, Singer DE, Freeman J, Gersh BJ, Mahaffey KW, Hylek EM, Naccarelli G, Piccini JP, Peterson ED, Pokorney SD. Patterns of oral anticoagulation use with cardioversion in clinical practice. Heart. 2021 04; 107(8):642-649. PMID: 32591363.

Published on 6/9/2020

Ko D, Kapoor A, Rose AJ, Hanchate AD, Miller D, Winter MR, Palmisano JN, Henault LE, Fredman L, Walkey AJ, Tripodis Y, Karcz A, Hylek EM. Temporal trends in pharmacologic prophylaxis for venous thromboembolism after hip and knee replacement in older adults. Vasc Med. 2020 10; 25(5):450-459. PMID: 32516054.

View full list of 270 publications.